Scancell Holdings plc
SCNLF · OTC
4/30/2025 | 10/31/2024 | 4/30/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Revenue | $5 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $4 | $0 | -$1 | -$0 |
| % Margin | 94.9% | – | – | – |
| R&D Expenses | $7 | $8 | $7 | $6 |
| G&A Expenses | $2 | $3 | $3 | $2 |
| SG&A Expenses | $2 | $3 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $11 | $10 | $8 |
| Operating Income | -$4 | -$11 | -$10 | -$8 |
| % Margin | -94.6% | – | – | – |
| Other Income/Exp. Net | $0 | -$3 | $5 | $5 |
| Pre-Tax Income | -$1 | -$14 | -$6 | -$4 |
| Tax Expense | $2 | $1 | -$2 | -$1 |
| Net Income | $0 | -$13 | -$3 | -$3 |
| % Margin | 4.9% | – | – | – |
| EPS | 0 | -0.014 | -0.004 | -0.003 |
| % Growth | 101.5% | -264.9% | -19.4% | – |
| EPS Diluted | 0 | -0.014 | -0.004 | -0.003 |
| Weighted Avg Shares Out | 1,013 | 929 | 899 | 819 |
| Weighted Avg Shares Out Dil | 1,011 | 929 | 899 | 819 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $0 |
| EBITDA | -$4 | -$10 | -$4 | -$3 |
| % Margin | -90.3% | – | – | – |